Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-19 4:15 pm Sale | 13G | Xilio Therapeutics Inc. XLO | GILEAD SCIENCES INC. GILD | 0 0.000% | -7,345,473 (Position Closed) | View |
| 2024-06-20 8:35 pm Sale | 13D | ASSEMBLY BIOSCIENCES INC. ASMB | GILEAD SCIENCES INC. GILD | 1,268,972 19.990% | -11,804,696 (-90.29%) | View |
| 2024-05-02 9:29 pm Purchase | 13D | GALAPAGOS NV SPONSORED ADR GLPG | GILEAD SCIENCES INC. GILD | 20,981,010 29.900% | 352,081 (+1.71%) | View |
| 2024-04-19 4:31 pm Purchase | 13G | LEAP THERAPEUTICS INC LPTX | GILEAD SCIENCES INC. GILD | 5,319,148 13.900% | 5,319,148 (New Position) | View |
| 2024-04-05 4:31 pm Purchase | 13G | Xilio Therapeutics Inc. XLO | GILEAD SCIENCES INC. GILD | 7,345,473 19.900% | 7,345,473 (New Position) | View |
| 2024-02-20 4:31 pm Purchase | 13G | KYVERNA THERAPEUTICS INC KYTX | GILEAD SCIENCES INC. GILD | 4,126,119 9.600% | 4,126,119 (New Position) | View |
| 2024-02-13 5:06 pm Sale | 13G | GILEAD SCIENCES INC. GILD | VANGUARD GROUP INC | 111,820,711 8.970% | -217,613 (-0.19%) | View |
| 2024-02-13 4:54 pm Purchase | 13G | Allovir Inc. ALVR | GILEAD SCIENCES INC. GILD | 16,635,286 14.600% | 2,930,870 (+21.39%) | View |
| 2024-02-13 4:51 pm Unchanged | 13G | TANGO THERAPEUTICS INC TNGX | GILEAD SCIENCES INC. GILD | 4,854,443 4.800% | 0 (Unchanged) | View |
| 2024-02-09 6:21 pm Purchase | 13G | GILEAD SCIENCES INC. GILD | Capital World Investors | 83,698,215 6.700% | 14,797,217 (+21.48%) | View |
| 2024-01-31 4:58 pm Purchase | 13D | Arcus Biosciences Inc. RCUS | GILEAD SCIENCES INC. GILD | 31,532,781 35.000% | 5,945,828 (+23.24%) | View |
| 2024-01-24 2:27 pm Sale | 13G | GILEAD SCIENCES INC. GILD | BlackRock Inc. BLK | 122,790,297 9.900% | -8,765,472 (-6.66%) | View |
| 2023-12-28 5:06 pm Purchase | 13G | Arcellx Inc. ACLX | GILEAD SCIENCES INC. GILD | 6,720,803 12.900% | 3,242,542 (+93.22%) | View |
| 2023-12-22 4:18 pm Purchase | 13G | HOOKIPA PHARMA INC HOOK | GILEAD SCIENCES INC. GILD | 18,759,465 19.400% | 15,000,000 (+398.99%) | View |
| 2023-10-25 5:18 pm Purchase | 13D | ASSEMBLY BIOSCIENCES INC. ASMB | GILEAD SCIENCES INC. GILD | 13,073,668 19.900% | 13,073,668 (New Position) | View |
| 2023-10-19 3:33 pm Purchase | 13G | IKENA ONCOLOGY INC IKNA | GILEAD SCIENCES INC. GILD | 2,931,467 6.700% | 2,931,467 (New Position) | View |
| 2023-07-06 09:38 am Purchase | 13D | Arcus Biosciences Inc. RCUS | GILEAD SCIENCES INC. GILD | 25,586,953 35.000% | 2,863,797 (+12.60%) | View |
| 2023-02-14 2:06 pm Unchanged | 13G | HOOKIPA PHARMA INC HOOK | GILEAD SCIENCES INC. GILD | 3,759,465 7.200% | 0 (Unchanged) | View |
| 2023-02-13 3:32 pm Sale | 13G | GILEAD SCIENCES INC. GILD | Capital Research Global Investors | 54,602,952 4.400% | -52,554,029 (-49.04%) | View |
| 2023-02-13 2:49 pm Purchase | 13G | GILEAD SCIENCES INC. GILD | Capital World Investors | 68,900,998 5.500% | 12,538,508 (+22.25%) | View |